HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
2019 ◽
Vol 30
(3)
◽
pp. 447-455
◽
Y. Wang
◽
T. Jiang
◽
Z. Qin
◽
J. Jiang
◽
Q. Wang
◽
...
2015 ◽
Vol 11
(3)
◽
pp. 385-397
◽
Fenlai Tan
◽
Yuankai Shi
◽
Yinxiang Wang
◽
Lieming Ding
◽
Xiaobin Yuan
◽
...
2021 ◽
Vol 16
(3)
◽
pp. S666-S667
K. Yamamoto
◽
M. Kuwahara
◽
S. Yamamoto
2014 ◽
Vol 25
◽
pp. iv452
K. Otsuka
◽
A. Hata
◽
R. Kato
◽
J. Takeshita
◽
C. Okuda
◽
...
2019 ◽
pp. 089719001984059
Emily Miao
◽
Nagashree Seetharamu
◽
Kevin Sullivan
◽
Stephen Eng
◽
Chung-Shien Lee
2014 ◽
Vol 25
◽
pp. iv450
T. Vavala
◽
A. Follador
◽
M. Tiseo
◽
D. Galetta
◽
A. Montanino
◽
...
2019 ◽
Vol 133
◽
pp. 145-159
◽
Nishant S. Kulkarni
◽
Vineela Parvathaneni
◽
Snehal K. Shukla
◽
Leonard Barasa
◽
Jeanette C. Perron
◽
...
Everton Mandley
◽
Kerry White
◽
Kerrie Faia
◽
Veronica Travaglione
◽
Margaret Read
◽
...
Farrukh Afaq
◽
Samriti Sharma
◽
Harish C. Pal
2019 ◽
Vol 11
(18)
◽
pp. 16336-16346
◽
Alexander M. Cryer
◽
Cheuk Chan
◽
Anastasia Eftychidou
◽
Christy Maksoudian
◽
Mohan Mahesh
◽
...